Back to today’s briefing

Story perspectives

U.S. Adult Obesity Rate Drops as Weight-Loss Drugs Surge

10/29/2025

36 6

Summary

Story summary

The U.S. adult obesity rate fell to 37% in 2025, from 39.9% in 2022, Gallup data show, representing 7.6 million fewer obese adults.
GLP-1 weight-loss drugs (glucagon-like peptide-1), such as Ozempic and Wegovy, have more than doubled to 12.4% of adults.
Most reductions occurred among adults aged 40 to 64, the primary users of these drugs.
Diabetes rates remain high at 13.8%, suggesting medication alone may not ensure health improvements.

1 of 1

Story summary

The U.S. adult obesity rate fell to 37% in 2025, from 39.9% in 2022, Gallup data show, representing 7.6 million fewer obese adults.
GLP-1 weight-loss drugs (glucagon-like peptide-1), such as Ozempic and Wegovy, have more than doubled to 12.4% of adults.
Most reductions occurred among adults aged 40 to 64, the primary users of these drugs.
Diabetes rates remain high at 13.8%, suggesting medication alone may not ensure health improvements.